Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis
The aim was to examine relationships between total and unbound mycophenolic acid (MPA) and prednisolone exposure and clinical outcomes in patients with lupus nephritis. METHODS: Six blood samples were drawn pre- and at 1, 2, 4, 6 and 8 h post-dose and total and unbound MPA and prednisolone pre-dos...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley & Sons, Inc.
2015
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/4/Rahman_et_al-2015-British_Journal_of_Clinical_Pharmacology.pdf |
id |
iium-44995 |
---|---|
recordtype |
eprints |
spelling |
iium-449952017-08-10T04:03:04Z http://irep.iium.edu.my/44995/ Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis Abd. Rahman, Nurul Azrin Tett, Susan E. Abdul Gafor, Abdul Halim McWhinney, Brett Staatz, Christine E. RM300 Drugs and their action RS Pharmacy and materia medica The aim was to examine relationships between total and unbound mycophenolic acid (MPA) and prednisolone exposure and clinical outcomes in patients with lupus nephritis. METHODS: Six blood samples were drawn pre- and at 1, 2, 4, 6 and 8 h post-dose and total and unbound MPA and prednisolone pre-dose (C0 ), maximum concentration (Cmax ) and area under the concentration-time curve (AUC) were determined using non-compartmental analysis in 25 patients. The analyses evaluated drug exposures in relation to treatment response since starting MPA and drug-related adverse events. RESULTS: Dose-normalized AUC varied 10-, 8-, 7- and 19-fold for total MPA, unbound MPA, total prednisolone and unbound prednisolone, respectively. Median values (95% CI) of total MPA AUC(0,8 h) (21.5 [15.0, 42.0] vs. 11.2 [4.8, 30.0] mg l-1 h, P= 0.048) and Cmax (11.9 [6.7, 26.3] vs. 6.1 [1.6, 9.2] mg l-1 , P = 0.016) were significantly higher in responders than non-responders. Anaemia was significantly associated with higher total (37.8 [14.1, 77.5] vs. 18.5 [11.7, 32.7] mg l-1 h, P = 0.038) and unbound MPA AUC(0,12 h) (751 [214, 830] vs. 227 [151, 389] mg l-1 h, P = 0.004). Unbound prednisolone AUC(0,24 h) was significantly higher in patients with Cushingoid appearance (unbound: 1372 [1242, 1774] vs. 846 [528, 1049] nmol l-1 h, P = 0.019) than in those without. Poorer treatment response was observed in patients with lowest tertile exposure to both total MPA and prednisolone as compared with patients with middle and higher tertile exposure (17% vs. 74%, P = 0.023). CONCLUSIONS: This study suggests a potential role for therapeutic drug monitoring in individualizing immunosuppressant therapy in patients with lupus nephritis. John Wiley & Sons, Inc. 2015-07-02 Article PeerReviewed application/pdf en http://irep.iium.edu.my/44995/4/Rahman_et_al-2015-British_Journal_of_Clinical_Pharmacology.pdf Abd. Rahman, Nurul Azrin and Tett, Susan E. and Abdul Gafor, Abdul Halim and McWhinney, Brett and Staatz, Christine E. (2015) Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis. British Journal of Clinical Pharmacology, 80 (5). pp. 1064-1075. ISSN 0306-5251 http://onlinelibrary.wiley.com/doi/10.1111/bcp.12678/abstract;jsessionid=AABBE5A02EE3E0C36FF879312BBDBB41.f02t03 10.1111/bcp.12678 |
repository_type |
Digital Repository |
institution_category |
Local University |
institution |
International Islamic University Malaysia |
building |
IIUM Repository |
collection |
Online Access |
language |
English |
topic |
RM300 Drugs and their action RS Pharmacy and materia medica |
spellingShingle |
RM300 Drugs and their action RS Pharmacy and materia medica Abd. Rahman, Nurul Azrin Tett, Susan E. Abdul Gafor, Abdul Halim McWhinney, Brett Staatz, Christine E. Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
description |
The aim was to examine relationships between total and unbound mycophenolic acid (MPA) and prednisolone exposure and clinical outcomes in patients with lupus nephritis.
METHODS:
Six blood samples were drawn pre- and at 1, 2, 4, 6 and 8 h post-dose and total and unbound MPA and prednisolone pre-dose (C0 ), maximum concentration (Cmax ) and area under the concentration-time curve (AUC) were determined using non-compartmental analysis in 25 patients. The analyses evaluated drug exposures in relation to treatment response since starting MPA and drug-related adverse events.
RESULTS:
Dose-normalized AUC varied 10-, 8-, 7- and 19-fold for total MPA, unbound MPA, total prednisolone and unbound prednisolone, respectively. Median values (95% CI) of total MPA AUC(0,8 h) (21.5 [15.0, 42.0] vs. 11.2 [4.8, 30.0] mg l-1 h, P= 0.048) and Cmax (11.9 [6.7, 26.3] vs. 6.1 [1.6, 9.2] mg l-1 , P = 0.016) were significantly higher in responders than non-responders. Anaemia was significantly associated with higher total (37.8 [14.1, 77.5] vs. 18.5 [11.7, 32.7] mg l-1 h, P = 0.038) and unbound MPA AUC(0,12 h) (751 [214, 830] vs. 227 [151, 389] mg l-1 h, P = 0.004). Unbound prednisolone AUC(0,24 h) was significantly higher in patients with Cushingoid appearance (unbound: 1372 [1242, 1774] vs. 846 [528, 1049] nmol l-1 h, P = 0.019) than in those without. Poorer treatment response was observed in patients with lowest tertile exposure to both total MPA and prednisolone as compared with patients with middle and higher tertile exposure (17% vs. 74%, P = 0.023).
CONCLUSIONS:
This study suggests a potential role for therapeutic drug monitoring in individualizing immunosuppressant therapy in patients with lupus nephritis. |
format |
Article |
author |
Abd. Rahman, Nurul Azrin Tett, Susan E. Abdul Gafor, Abdul Halim McWhinney, Brett Staatz, Christine E. |
author_facet |
Abd. Rahman, Nurul Azrin Tett, Susan E. Abdul Gafor, Abdul Halim McWhinney, Brett Staatz, Christine E. |
author_sort |
Abd. Rahman, Nurul Azrin |
title |
Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
title_short |
Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
title_full |
Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
title_fullStr |
Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
title_full_unstemmed |
Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
title_sort |
exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis |
publisher |
John Wiley & Sons, Inc. |
publishDate |
2015 |
url |
http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/ http://irep.iium.edu.my/44995/4/Rahman_et_al-2015-British_Journal_of_Clinical_Pharmacology.pdf |
first_indexed |
2023-09-18T21:03:59Z |
last_indexed |
2023-09-18T21:03:59Z |
_version_ |
1777410810522370048 |